Annual Non Current Assets
$1.93 M
-$99.90 K-4.93%
December 31, 2023
Summary
- As of February 7, 2025, ENTO annual long term assets is $1.93 million, with the most recent change of -$99.90 thousand (-4.93%) on December 31, 2023.
- During the last 3 years, ENTO annual non current assets has fallen by -$3.13 million (-61.87%).
- ENTO annual non current assets is now -67.41% below its all-time high of $5.91 million, reached on December 1, 2014.
Performance
ENTO Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$1.98 M
+$77.90 K+4.10%
September 1, 2024
Summary
- As of February 7, 2025, ENTO quarterly long term assets is $1.98 million, with the most recent change of +$77.90 thousand (+4.10%) on September 1, 2024.
- Over the past year, ENTO quarterly non current assets has increased by +$51.40 thousand (+2.67%).
- ENTO quarterly non current assets is now -97.63% below its all-time high of $83.64 million, reached on March 31, 2024.
Performance
ENTO Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
ENTO Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.9% | +2.7% |
| 3 y3 years | -61.9% | -1.3% |
| 5 y5 years | -27.8% | -65.3% |
ENTO Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.5% | at low | -97.6% | +4.1% |
| 5 y | 5-year | -64.9% | at low | -97.6% | +4.1% |
| alltime | all time | -67.4% | at low | -97.6% | +4.1% |
Entero Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.98 M(+4.1%) |
| Jun 2024 | - | $1.90 M(-97.7%) |
| Mar 2024 | - | $83.64 M(+4240.6%) |
| Dec 2023 | $4.96 M(+45.2%) | $1.93 M(-1.2%) |
| Sep 2023 | - | $1.95 M(-1.2%) |
| Jun 2023 | - | $1.97 M(-1.5%) |
| Mar 2023 | - | $2.00 M(-1.1%) |
| Dec 2022 | $3.41 M(-63.8%) | - |
| Dec 2022 | - | $2.03 M(-3.3%) |
| Sep 2022 | - | $2.10 M(-2.0%) |
| Jun 2022 | - | $2.14 M(-6.0%) |
| Mar 2022 | - | $2.28 M(-3.8%) |
| Dec 2021 | $9.43 M(+19.8%) | $2.37 M(-51.9%) |
| Sep 2021 | - | $4.92 M(-4.6%) |
| Jun 2021 | - | $5.16 M(+7.3%) |
| Mar 2021 | - | $4.81 M(-4.8%) |
| Dec 2020 | $7.87 M | $5.05 M(-2.5%) |
| Sep 2020 | - | $5.18 M(-1.5%) |
| Jun 2020 | - | $5.26 M(-0.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $5.29 M(-3.8%) |
| Dec 2019 | $3.41 M(-29.0%) | $5.49 M(-3.7%) |
| Sep 2019 | - | $5.71 M(-4.6%) |
| Jun 2019 | - | $5.98 M(-2.7%) |
| Mar 2019 | - | $6.15 M(+130.5%) |
| Dec 2018 | $4.80 M(+145.8%) | $2.67 M(-7.8%) |
| Sep 2018 | - | $2.90 M(-6.8%) |
| Jun 2018 | - | $3.11 M(-9.8%) |
| Mar 2018 | - | $3.44 M(-2.4%) |
| Dec 2017 | $1.95 M(-34.1%) | $3.53 M(-3.4%) |
| Sep 2017 | - | $3.65 M(-2.2%) |
| Jun 2017 | - | $3.73 M(+1.6%) |
| Mar 2017 | - | $3.67 M(-3.1%) |
| Dec 2016 | $2.96 M(+43.4%) | $3.79 M(-10.3%) |
| Sep 2016 | - | $4.22 M(-2.3%) |
| Jun 2016 | - | $4.32 M(-6.4%) |
| Mar 2016 | - | $4.62 M(+0.1%) |
| Dec 2015 | $2.07 M(+211.6%) | $4.62 M |
| Dec 2014 | $663.50 K | - |
FAQ
- What is Entero Therapeutics annual long term assets?
- What is the all time high annual non current assets for Entero Therapeutics?
- What is Entero Therapeutics annual non current assets year-on-year change?
- What is Entero Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Entero Therapeutics?
- What is Entero Therapeutics quarterly non current assets year-on-year change?
What is Entero Therapeutics annual long term assets?
The current annual non current assets of ENTO is $1.93 M
What is the all time high annual non current assets for Entero Therapeutics?
Entero Therapeutics all-time high annual long term assets is $5.91 M
What is Entero Therapeutics annual non current assets year-on-year change?
Over the past year, ENTO annual long term assets has changed by -$99.90 K (-4.93%)
What is Entero Therapeutics quarterly long term assets?
The current quarterly non current assets of ENTO is $1.98 M
What is the all time high quarterly non current assets for Entero Therapeutics?
Entero Therapeutics all-time high quarterly long term assets is $83.64 M
What is Entero Therapeutics quarterly non current assets year-on-year change?
Over the past year, ENTO quarterly long term assets has changed by +$51.40 K (+2.67%)